Skip Navigation


The MUSC Biorespository Network


There are currently multiple repositories on the MUSC campus that operate independently. These facilities include:

Each of these biorepositories varies in access by faculty and students, samples collected, linkage to clinical data, and support from grants, centers, colleges and the University.   A coordinated biorepository effort that promotes best practices and standardization for each collection, IT infrastructure for management of biospecimens, linkage of samples to clinical data, and access to the MUSC community with appropriate governance and request mechanisms has resulted, with the following objectives:

Strategic Goal: “To develop a university-wide, state-of-the art  MUSC Tissue Biorepository network that advances the research, service, and educational missions of MUSC”.

Organization and Leadership:

Centralized oversight is critical to a successfully integrated system. The facility is led by a Director and Advisory Team with the experience to develop a state-of-the-art facility that provides access to repository resources across the MUSC campus.

Director: Richard R. Drake, PhD

  Professor, Endowed Chair Proteomics, Department of Pharmacology

Biorepository Advisory Committee:

Lotta Granholm-Bentley

Kwanda (Kiki) Gibbs

Bill Morgenweck

Jim Oates

Mary Richardson

Susan Sonne


Information Technology:

A priority for the MUSC biorepository is integration of samples with clinical information. The IT infrastructure for managing sample collections and the development of software that allows users to search for samples from donors with specific phenotypes is the biorepository query tool, aka, TissueTracker.  This program allows investigators to search for samples in the Hollings Cancer Center, SCTR and the Brain Bank collections and may be accessed by the Biorepository Query Tool: 

If you have questions regarding this tool contact Bill Morgenweck at

Regulatory Considerations:

The MUSC biorepository will comply with all applicable privacy rules and regulations, as well as the appropriate human subjects protection regulations that govern the acquisition of biospecimens associated with clinical data. Additionally, the biorepository will focus on compliance with applicable federal regulations and current MUSC guidelines regarding informed consent, access to biospecimens and data, privacy protection, ownership/custodianship, and intellectual property.  IRB information may be found at


© 2012  Medical University of South Carolina | Disclaimer Web Administrator